ICI 169,369 is both a competitive antagonist and an allosteric activator of the arterial 5-hydroxytryptamine2 receptor system
(Q43800060)
scientific article published in June 1988
scientific article published in June 1988
Language:
Current Data About
ICI 169,369 is both a competitive antagonist and an allosteric activator of the arterial 5-hydroxytryptamine2 receptor system
| (P31) |
(Q13442814)
|
||||||||||||||||
| (P304) |
1010-1015
|
||||||||||||||||
| (P407) |
(Q1860)
|
||||||||||||||||
| (P433) |
3
|
||||||||||||||||
| (P478) |
245
|
||||||||||||||||
| (P577) |
Wednesday, June 1, 1988
|
||||||||||||||||
| (P1433) |
(Q1500272)
|
||||||||||||||||
| (P1476) |
"ICI 169,369 is both a competitive antagonist and an allosteric activator of the arterial 5-hydroxytryptamine2 receptor system" (language: en)
|
||||||||||||||||
| (P2093) |
Kaumann AJ
Frenken M
|